Caresyntax Appoints Matt Krueger as New CEO to Lead Surgical Intelligence Growth

Caresyntax Elevates Matt Krueger to CEO

On July 16, 2025, Caresyntax, a leader in surgical intelligence, announced the appointment of Matt Krueger as its Chief Executive Officer. This strategic move comes as Krueger takes over from the company's founders, Dennis Kogan and Bjoern von Siemens, who will continue to serve on the Board of Directors while supporting corporate development and capital markets strategies.

Over the past decade, Krueger has played a crucial role in the company's expansion and success. Under his guidance as President, Caresyntax experienced phenomenal growth, now operating in over 4,200 surgical centers globally and contributing to more than three million surgical procedures each year. During this period, the firm consistently achieved over 50% organic revenue growth, which is a testament to Krueger's effective leadership.

Both Kogan and von Siemens praised Krueger’s capabilities, acknowledging his integral part in nurturing Caresyntax’s global outreach and strengthening strategic partnerships. They expressed confidence in his vision for the future, indicating that Krueger's ample understanding of customer needs and organizational scaling would be vital as Caresyntax advances its mission of making surgeries safer, smarter, and more interconnected.

In an official statement, Krueger highlighted the tremendous opportunity that lies ahead for Caresyntax. He remarked, “We find ourselves at an intersection of artificial intelligence, clinical data, and surgical decision-making, and our future prospects are more promising than ever.” He assured the stakeholder community that efforts would be made to further the company’s global reach, foster deeper collaborations with surgical teams, and enhance the provision of real-time, evidence-based insights during surgeries.

Caresyntax has garnered a strong reputation for its contributions to surgical intelligence. Headquartered in both San Francisco and Berlin, the firm aspires to ensure that every surgical procedure is guided by data-driven insights, which enhances outcomes and operational efficiencies. As Krueger embarks on this new chapter, he is excited to lead a talented team toward realizing Caresyntax's vision, embracing advancements in technology and partnering strategically to transform the surgical landscape.

The legacy of Caresyntax's founders will surely continue, with Kogan and von Siemens remaining actively engaged in steering the company’s corporate strategy and governance. They will have the opportunity to support Krueger's leadership while ensuring the foundational principles of Caresyntax remain central to its operations.

As the medical industry continues to evolve, the demand for data-driven solutions in surgical procedures grows. Caresyntax stands ready to meet these demands by leveraging Krueger’s leadership and the company’s cutting-edge approach to integrating technology and clinical data in surgery. This appointment signals not only a change in leadership but a continued commitment to innovation and improvement in surgical care worldwide.

For further details about Caresyntax and its mission, visit Caresyntax.com.